Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Cletoquine oxalate；Desethylhydroxychloroquine oxalate | C18H24ClN3O5 | 14142-64-4 | Details |
| CK2/PIM1-IN-1 | C15H9NO4S2 | 292640-28-9 | Details |
| CKI-7 free base；CKI-7 | C11H12ClN3O2S | 120615-25-0 | Details |
| Cl-amidine | C14H19ClN4O2 | 913723-61-2 | Details |
| Cipemastat；Ro 32-3555 | C22H36N4O5 | 190648-49-8 | Details |
| Cinnarizine D8 | C26H28N2 | 1185242-27-6 | Details |
| Cicloprolol hydrochloride | C18H30ClNO4 | 63686-79-3 | Details |
| CK2/ERK8-IN-1 | C11H9Br4N3O2 | 1085822-09-8 | Details |
| Theophylline | C7H8N4O2 | 58-55-9 | Details |
| CL 316243 | C20H18ClNO7.2Na | 138908-40-4 | Details |
| Cl-amidine hydrochloride | C14H20Cl2N4O2 | 1373232-26-8 | Details |
| CLK1-IN-1 | C24H16FN5O | 2123491-32-5 | Details |
| Cipropride S enantiomer | C17H25N3O4S | 66183-70-8 | Details |
| Cinnamoylglycine | C11H11NO3 | 16534-24-0 | Details |
| Closthioamide | C29H38N6O2S6 | 1227367-59-0 | Details |
| Cletoquine | C16H22ClN3O | 4298-15-1 | Details |
| CHMFL-ABL/KIT-155；CHMFL-ABL-KIT-155 | C33H38F3N5O3 | 2081093-21-0 | Details |
| CHMFL-EGFR-202 | C25H24ClN7O2 | 2089381-40-6 | Details |
| CHMFL-KIT-033 | C23H18FN5O2 | 2351801-41-5 | Details |
| Cholesterol glucuronide | C33H54O7 | 17435-78-8 | Details |
| Cholesteryl arachidonate | C47H76O2 | 604-34-2 | Details |
| Cholesteryl Linolenate | C45H74O2 | 2545-22-4 | Details |
| CHPG | C8H8ClNO3 | 170846-74-9 | Details |
| CHMFL-PI3KD-317 | C21H24ClN5O3S2 | 2244992-76-3 | Details |
| CHPG sodium salt | C8H7ClNNaO3 | 1303993-73-8 | Details |
| Chromomycin A3 | C57H82O26 | 7059-24-7 | Details |
| Naftidrofuryl oxalate | C26H35NO7 | 3200-06-4 | Details |
| Ciraparantag；PER977 | C22H48N12O2 | 1438492-26-2 | Details |
| Ciraparantag TFA；PER977 TFA | C24H49F3N12O4 | 1438492-27-3 | Details |
| Cirsimarin | C23H24O11 | 13020-19-4 | Details |
| trans-Pralsetinib；cis-Pralsetinib;cis-BLU-667 | C27H32FN9O2 | 2097132-93-7 | Details |
| Citrinin；NSC 186 | C13H14O5 | 518-75-2 | Details |
| Cl-amidine TFA | C14H19ClN4O2 ? CF3CO2H | 1043444-18-3 | Details |
| CL2-SN-38 | C82H106N12O23 | 1036969-20-6 | Details |
| CL264 | C19H23N7O4 | 1510712-69-2 | Details |
| CL656；c-[2’FdAMP(S)-2’FdIMP(S)] | C20H21F2N9O9P2S2 | 1951464-79-1 | Details |
| Chymase-IN-1 | C20H15ClNO4PS | 862090-74-2 | Details |
| Cilobradine hydrochloride | C28H38N2O5.ClH | 186097-54-1 | Details |
| Cinacalcet metabolite M4 | C10H12F3N | 104774-87-0 | Details |
| Benzyl isothiocyanate | C8H7NS | 622-78-6 | Details |
| Cirsiliol | C17H14O7 | 34334-69-5 | Details |
| cis-Urocanic acid | C6H6N2O2 | 7699-35-6 | Details |
| CK-666 | C18H17FN2O | 442633-00-3 | Details |
| Clozic | C17H17ClO3 | 22494-47-9 | Details |
| Theophylline monohydrate | C7H10N4O3 | 5967-84-0 | Details |
| Apramycin sulfate | C21H43N5O15S | 65710-07-8 | Details |
| Clocapramine；Clocarpramine;3-Chlorocarpipramine | C28H37ClN4O | 47739-98-0 | Details |
| Clocapramine dihydrochloride hydrate；3-Chlorocarpipramine hydrochloride hydrate;Clocapramine hydrochloride hydrate | C28H40Cl2N4O2 | 60789-62-0 | Details |
| Clomipramine D3 | C18H19ClD3N3 | 136765-29-2 | Details |
| CM-579 | C29H40N4O3 | 1846570-40-8 | Details |
| CM-675 | C31H32N6O3 | 1872466-47-1 | Details |
| CRA-026440 | C23H24N4O4 | 847460-34-8 | Details |
| CRAC intermediate 1 | C10H7F2N3O | 1249343-86-9 | Details |
| Clomipramine D3 hydrochloride | C19H24Cl2N2 | 1398065-86-5 | Details |
| CMF019 | C25H33N3O3S | 1586787-08-7 | Details |
| CMI-392 | C31H37ClN2O8S | 205654-37-1 | Details |
| CMK | C18H19ClN4O2 | 821794-90-5 | Details |
| CMLD010509；SDS-1-021 | C27H26BrNO7 | 256497-58-2 | Details |
| CO23 | C19H18I2N2O4 | 1370363-74-8 | Details |
| CMP-5 | C21H21N3 | 880813-42-3 | Details |
| L-Glutathione reduced | C10H17N3O6S | 70-18-8 | Details |
| CMLD012072 | C32H32N2O7 | 2368900-33-6 | Details |
| Corin | C26H28N4O2 | 1808113-09-8 | Details |
| Vitamin D2 | C28H44O | 50-14-6 | Details |
| Glutathione oxidized | C20H32N6O12S2 | 27025-41-8 | Details |
| COH34 | C18H15NOS | 906439-72-3 | Details |
| Collagen proline hydroxylase inhibitor | C18H18N4O4 | 223666-07-7 | Details |
| Collagen proline hydroxylase inhibitor-1 | C24H21N5O4 | 223663-32-9 | Details |
| COH34 analog 1 | C18H15NO3S | 314248-24-3 | Details |
| CNT2 inhibitor-1 | C23H24N6O4 | 880155-70-4 | Details |
| CNS-5161 hydrochloride | C16H19Cl2N3S2 | 160756-38-7 | Details |
| Coenzyme A | C21H36N7O16P3S | 85-61-0 | Details |
| Col003 | C14H11NO4 | 328565-16-8 | Details |
| Complement C5-IN-1 | C24H32N2O6 | 2365402-67-9 | Details |
| CPPHA | C22H15ClN2O4 | 693288-97-0 | Details |
| CPI-0610 carboxylic acid | C20H15ClN2O3 | 1380089-81-5 | Details |
| CP-96021 hydrochloride | C29H22ClFN4OS | 167011-22-5 | Details |
| CP-809101 hydrochloride | C15H18Cl2N4O | 1215721-40-6 | Details |
| CMP-Sialic acid sodium salt；CMP-Neu5Ac sodium salt | C20H32N4NaO16P | 1007117-62-5 | Details |
| Cot inhibitor-1 | C27H27Cl2FN8 | 915365-57-0 | Details |
| CP-409092 | C17H19N3O2 | 194098-25-4 | Details |
| CP-96486 | 139401-45-9 | Details |
| CP-060 | C30H42N2O5S | 180090-15-7 | Details |
| CP-409092 hydrochloride | C17H20ClN3O2 | 225240-86-8 | Details |
| Repaglinide | C27H36N2O4 | 135062-02-1 | Details |
| CPUY074020 | C25H28N4O2 | 902279-44-1 | Details |
| CP-547632 hydrochloride | C20H25BrClF2N5O3S | 252003-71-7 | Details |
| CNX-500 | C48H68N10O9S | 1202758-21-1 | Details |
| CP-28888；CP 28888-27 | C40H76N2 | 69938-75-6 | Details |
| CMLD012612 | C31H33N3O7 | 2368900-35-8 | Details |
| Cot inhibitor-2 | C26H25Cl2FN8 | 915363-56-3 | Details |
| CPA inhibitor | C18H19NO4 | 223532-02-3 | Details |
| CPPG；(RS)-CPPG | C11H14NO5P | 183364-82-1 | Details |
| CP-547632 | C20H24BrF2N5O3S | 252003-65-9 | Details |
| CPDA | C20H15ClF2N2O2 | 1415834-63-7 | Details |
| CPFX2090 | C28H28ClNO6 | 1429439-25-7 | Details |
| Valacyclovir hydrochloride | C13H20N6O4.ClH | 124832-27-5 | Details |
| Coumetarol；Ph 137;Dicumoxane | C21H16O7 | 4366-18-1 | Details |
| Cobimetinib (R-enantiomer)；XL-518 R-enantiomer;GDC-0973 R-enantiomer;Cobimetinib R-enantiomer | C21H21F3IN3O2 | 934660-94-3 | Details |
| CMLD012073 | C30H30N2O7 | 2368900-32-5 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 | ||||